Neurological Disorders: Language & Behavior Issues
Studies discussed include neuropsychiatric symptoms leading to mild cognitive impairment and gesture comprehension and language in children with autism.
Aging and Dementia: AAN 2017
Studies examined the impact of blood pressure trajectories on dementia risk and explored the relationship between sleep apnea and Aβ accumulations.
Epilepsy Highlights: AAN 2017
Highlights: imaging the temporal dynamics & cellular architecture of seizures in Dravet syndrome, & reducing risk of spontaneous fetal loss.
Chronic Traumatic Encephalopathy: Potential Biomarker
Blood protein analysis of plasma total tau has diagnostic use in Alzheimer disease. Could the same hold true for CTE?
Acute Stroke Treatment and Outcomes: AAN 2017
The effect of blood pressure on IAT safety and benefit and pediatric stroke outcomes based on treatment were some of the studies presented at AAN.
Best of MS: AAN 2017
The four top-scoring MS abstracts submitted for AAN 2017 included 6-year outcomes with alemtuzumab treatment and pediatric MS environmental risk factors.
Migraine Prevention: Promising New Drug
Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.
Exploratory Trial for Essential Tremor Treatment
In a proof-of-concept study, 25 patients were exposed to a dose-escalating infusion of SAGE-547 to evaluate the drug’s effect on essential tremor.
Modeling Simulations to Predict AED Efficacy
Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).
By clicking Accept, you agree to become a member of the UBM Medica Community.